{
  "id": 15610561,
  "title": "Merck KGaA to buy Silence Therapeutics and its siRNA pipeline for $1.3B",
  "url": "https://urgent.news/2026/10/19/merck-kgaa-to-buy-silence-therapeutics-and-its-sirna-pipeline-for-1-3b",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-19T13:57:45.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/merck-kgaa-will-buy-silence-therapeutics-and-its-sirna-pipeline-for-1-3b/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Germany's Merck KGaA agreed to buy UK drug developer Silence Therapeutics for $1.3 billion, building out its work in rare and specialty diseases using genetic medicines. Silence is developing the siRNA drug divesiran, which is ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}